Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence

Clinical and Experimental Metastasis

Volumn 29, Issue 6, 2012, Pages 561-572

  Ito, Koichi ^a   Ralph, Stephen J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Cancer cell adhesion; Cancer stem cells; CD44 and CD326; Galectin 1; Lung metastasis; T cells

Indexed keywords

CD44V ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; GALACTOSIDE; GALECTIN 1; LAMININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; LUNG METASTASIS; LUNG WEIGHT; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; FEMALE; GALECTIN 1; HUMANS; IN SITU NICK-END LABELING; LAMININ; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEOGLYCANS;

EID: 84863718828     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9471-7     Document Type: Article

References (49)

1. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274-284
2. Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359(26):2814-2823
3. Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH (2009) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29(8):1093-1102
4. Nicol AJ, Tokuyama H, Mattarollo SR, Hagi T, Suzuki K, Yo-kokawa K, Nieda M (2011) Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours. Br J Cancer 105(6):778-786
5. Talmadge JE (2010) Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact. Semin Cancer Biol 21(2):131-138
6. Yang L (2010) TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy. Curr Mol Med 10(4):374-380
7. Prendergast GC (2008) Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene 27(28):3889-3900
8. Rabinovich GA (2005) Galectin-1 as a potential cancer target. Br J Cancer 92(7):1188-1192
9. Kortylewski M, Yu H (2008) Role of Stat3 in suppressing antitumor immunity. Curr Opin Immunol 20(2):228-233
10. Watanabe MA, Oda JM, Amarante MK, Cesar Voltarelli J (2010) Regulatory T cells and breast cancer: implications for immuno-pathogenesis. Cancer Metastasis Rev 29(4):569-579
11. Iiizumi M, Mohinta S, Bandyopadhyay S, Watabe K (2007) Tumor-endothelial cell interactions: therapeutic potential. Mi-crovasc Res 74(2-3):114-120
12. Miles FL, Pruitt FL, van Golen KL, Cooper CR (2008) Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 25(4):305-324
13. Klingbeil P, Marhaba R, Jung T, Kirmse R, Ludwig T, Zoller M (2009) CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Mol Cancer Res 7(2):168-179
14. Baeuerle PA, Gires O (2007) EpCAM (CD326) finding its role in cancer. Br J Cancer 96(3):417-423
15. Frank NY, Schatton T, Frank MH (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120(1):41-50
16. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8(8):784-804
17. Li F, Tiede B, Massague J, Kang Y (2007) Beyond tumorigen-esis: cancer stem cells in metastasis. Cell Res 17(1):3-14
18. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K et al (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76(4):597-598
19. Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5(1):29-41
20. Yang RY, Rabinovich GA, Liu FT (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17
21. Perillo NL, Pace KE, Seilhamer JJ, Baum LG (1995) Apoptosis of T cells mediated by galectin-1. Nature 378(6558):736-739
22. Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, Giaccia AJ, Koong AC, Le QT (2011) Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 71(13):4423-4431
23. Kovacs-Solyom F, Blasko A, Fajka-Boja R, Katona RL, Vegh L, Novak J, Szebeni GJ, Krenacs L, Uher F, Tubak V, Kiss R, Monostori E (2010) Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 127(2):108-118
24. Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG (2000) CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol 165(5):2331-2334
25. ?T cells. Blood 109(5):2058-2065
26. Tinari N, Kuwabara I, Huflejt ME, Shen PF, Iacobelli S, Liu FT (2001) Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer 91(2):167-172
27. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, Gabius HJ, Kiss R, Camby I (2003) Upregulation of galectins-1 and-3 in human colon cancer and their role in regulating cell migration. Int J Cancer 103(3):370-379
28. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R (2002) Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61(7):585-596
29. Clausse N, van den Brule F, Waltregny D, Garnier F, Castronovo V (1999) Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis 3(4):317-325
30. Thijssen VL, Hulsmans S, Griffioen AW (2008) The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 172(2): 545-553
31. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103(43):15975-15980
32. Ito K, Scott SA, Cutler S, Dong LF, Neuzil J, Blanchard H, Ralph SJ (2011) Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress. Angiogen-esis 14(3):293-307
33. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, Griffioen AW (2010) Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 70(15):6216-6224
34. Stannard KA, Collins PM, Ito K, Sullivan EM, Scott SA, Gabutero E, Darren Grice I, Low P, Nilsson UJ, Leffler H, Blanchard H, Ralph SJ (2010) Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett 299(2):95-110
35. Camp RL, Scheynius A, Johansson C, Pure E (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178(2):497-507
36. Barrow H, Rhodes JM, Yu LG (2011) The role of galectins in colorectal cancer progression. Int J Cancer 129(1):1-8
37. Ohannesian DW, Lotan D, Lotan R (1994) Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Cancer Res 54(22):5992-6000
38. Baum LG, Pang M, Perillo NL, Wu T, Delegeane A, Uittenb-ogaart CH, Fukuda M, Seilhamer JJ (1995) Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 181(3):877-887
39. Motran CC, Molinder KM, Liu SD, Poirier F, Miceli MC (2008) Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur J Immunol 38(11):3015-3027
40. Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC (2000) Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 165(7):3722-3729
41. Delaine T, Cumpstey I, Ingrassia L, Le Mercier M, Okechukwu P, Leffler H, Kiss R, Nilsson UJ (2008) Galectin-inhibitory thi-odigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells. J Med Chem 51(24):8109-8114
42. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24-37
43. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Mol-idor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654-2666
44. Harrington LE, Galvan M, Baum LG, Altman JD, Ahmed R (2000) Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J Exp Med 191(7):1241-1246
45. Galvan M, Tsuboi S, Fukuda M, Baum LG (2000) Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 275(22):16730-16737
46. Rambaruth ND, Dwek MV (2011) Cell surface glycan-lectin interactions in tumor metastasis. Acta Histochem 113(6):591-600
47. Fidler IJ, Talmadge JE (1986) Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res 46(10):5167-5171
48. Pace KE, Lee C, Stewart PL, Baum LG (1999) Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 163(7):3801-3811
49. Skelton TP, Zeng C, Nocks A, Stamenkovic I (1998) Glycosyl-ation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 140(2):431-446